In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell Carcinoma

被引：1
|
作者：
Fan, Alice C. [2 ]
Leppert, John T. [1 ]
机构：
[1] Stanford Univ, Dept Urol, Sch Med, 300 Pasteur Dr,Grant S-287, Stanford, CA 94305 USA
[2] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 01期
关键词：
D O I：
10.1001/jamanetworkopen.2020.35120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
    Yu, Jiwoong
    Ahn, Hyeonju
    Han, Kyung Yeon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Park, Se Hoon
    Park, Woong-Yang
    Lee, Ji Hyun
    Kang, Minyong
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (02)
  • [22] Acute renal failure in patient with renal cell carcinoma after combination immune checkpoint inhibitor therapy
    Zang, Peter D.
    Lee, Ramon O.
    Smith, Joshua A.
    CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2021, 4
  • [23] Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
    Ivan Pourmir
    Johanna Noel
    Audrey Simonaggio
    Stéphane Oudard
    Yann-Alexandre Vano
    World Journal of Urology, 2021, 39 : 1377 - 1385
  • [24] Update on the most promising biomarkers of response to immune checkpoint inhibitors in clear cell renal cell carcinoma
    Pourmir, Ivan
    Noel, Johanna
    Simonaggio, Audrey
    Oudard, Stephane
    Vano, Yann-Alexandre
    WORLD JOURNAL OF UROLOGY, 2021, 39 (05) : 1377 - 1385
  • [25] Response to Immune Checkpoint Therapy and Clinical Outcome is Not Related to Proportion of Sarcomatous Component in Sarcomatoid Renal Cell Carcinoma
    Oramas, Diana
    Kim, TaeBeom
    Chen, Ken
    Rao, Priya
    Tamboli, Pheroze
    Karam, Jose
    Shapiro, Daniel
    Sircar, Kanishka
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 950 - 952
  • [26] Response to Immune Checkpoint Therapy and Clinical Outcome is Not Related to Proportion of Sarcomatous Component in Sarcomatoid Renal Cell Carcinoma
    Oramas, Diana
    Kim, TaeBeom
    Chen, Ken
    Rao, Priya
    Tamboli, Pheroze
    Karam, Jose
    Shapiro, Daniel
    Sircar, Kanishka
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 950 - 952
  • [27] Neoadjuvant Checkpoint Inhibitor Therapy for Merkel Cell Carcinoma
    Brohl, Andrew S.
    Sondak, Vernon K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (22) : 2471 - +
  • [28] Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
    Ivanova, Elizaveta
    Asadullina, Dilara
    Gilyazova, Gulshat
    Rakhimov, Radmir
    Izmailov, Adel
    Pavlov, Valentin
    Khusnutdinova, Elza
    Gilyazova, Irina
    BIOMEDICINES, 2023, 11 (03)
  • [29] New biomarkers for checkpoint inhibitor therapy
    Burdett, Nikki
    Desai, Jayesh
    ESMO OPEN, 2020, 5
  • [30] Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
    Lee, Chung-Han
    Motzer, Robert
    BRITISH JOURNAL OF CANCER, 2018, 119 (08) : 911 - 912
12345